These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27295974)

  • 21. [Diagnosis and Treatment of Cognitive Impairment in Parkinson's Disease].
    Shiraishi T; Murakami H; Iguchi Y
    Brain Nerve; 2019 Aug; 71(8):869-874. PubMed ID: 31346143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Onset of Mild Cognitive Impairment in Parkinson Disease.
    Johnson DK; Langford Z; Garnier-Villarreal M; Morris JC; Galvin JE
    Alzheimer Dis Assoc Disord; 2016; 30(2):127-33. PubMed ID: 25850732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.
    Gasser AI; Calabrese P; Kalbe E; Kessler J; Rossier P
    Rev Neurol (Paris); 2016 Feb; 172(2):138-45. PubMed ID: 26494570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Subtypes of mild cognitive impairment in Parkinson's disease and factors predicting its becoming dementia].
    Toribio-Diaz ME; Carod-Artal FJ
    Rev Neurol; 2015 Jul; 61(1):14-24. PubMed ID: 26108904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of Parkinson's disease dementia related to level I MDS PD-MCI.
    Hoogland J; Boel JA; de Bie RMA; Schmand BA; Geskus RB; Dalrymple-Alford JC; Marras C; Adler CH; Weintraub D; Junque C; Pedersen KF; Mollenhauer B; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ;
    Mov Disord; 2019 Mar; 34(3):430-435. PubMed ID: 30653248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial cognitive changes in Parkinson's disease.
    Weintraub D; Tröster AI; Marras C; Stebbins G
    Mov Disord; 2018 Apr; 33(4):511-519. PubMed ID: 29543342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive impairment in nondemented Parkinson's disease.
    Barone P; Aarsland D; Burn D; Emre M; Kulisevsky J; Weintraub D
    Mov Disord; 2011 Dec; 26(14):2483-95. PubMed ID: 22170275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease.
    Orgeta V; McDonald KR; Poliakoff E; Hindle JV; Clare L; Leroi I
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD011961. PubMed ID: 32101639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinson's and Alzheimer's diseases: Focus on mild cognitive impairment.
    Korczyn AD
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S159-61. PubMed ID: 26516060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COGTIPS: a double-blind randomized active controlled trial protocol to study the effect of home-based, online cognitive training on cognition and brain networks in Parkinson's disease.
    van Balkom TD; Berendse HW; van der Werf YD; Twisk JWR; Zijlstra I; Hagen RH; Berk T; Vriend C; van den Heuvel OA
    BMC Neurol; 2019 Jul; 19(1):179. PubMed ID: 31366395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
    Riedel O; Klotsche J; Spottke A; Deuschl G; Förstl H; Henn F; Heuser I; Oertel W; Reichmann H; Riederer P; Trenkwalder C; Dodel R; Wittchen HU
    J Neurol; 2008 Feb; 255(2):255-64. PubMed ID: 18204803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mild cognitive impairment in Parkinson's disease.
    Martinez-Horta S; Kulisevsky J
    J Neural Transm (Vienna); 2019 Jul; 126(7):897-904. PubMed ID: 30963293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive complaints in Parkinson's disease patients: from subjective cognitive complaints to dementia and affective disorders.
    Barbosa RP; Mendonça MD; Caetano AP; Lampreia TM; Miguel R; Bugalho PM
    J Neural Transm (Vienna); 2019 Oct; 126(10):1329-1335. PubMed ID: 31278557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epidemiology of cognitive function in Parkinson's disease.
    Bock MA; Tanner CM
    Prog Brain Res; 2022; 269(1):3-37. PubMed ID: 35248199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis.
    Saredakis D; Collins-Praino LE; Gutteridge DS; Stephan BCM; Keage HAD
    Parkinsonism Relat Disord; 2019 Aug; 65():20-31. PubMed ID: 31109727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroimaging correlates of cognitive impairment and dementia in Parkinson's disease.
    Mak E; Su L; Williams GB; O'Brien JT
    Parkinsonism Relat Disord; 2015 Aug; 21(8):862-70. PubMed ID: 26004683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Education-corrected CERAD identifies MCI and dementia in Parkinson's disease.
    Karrasch M; Laatu S; Ellfolk U; Marttila R; Martikainen K
    Acta Neurol Scand; 2015 Apr; 131(4):219-24. PubMed ID: 25273524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dementia Predictors in Parkinson Disease: A Validation Study.
    Anang JB; Nomura T; Romenets SR; Nakashima K; Gagnon JF; Postuma RB
    J Parkinsons Dis; 2017; 7(1):159-162. PubMed ID: 27911340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher vitamin B12 level at Parkinson's disease diagnosis is associated with lower risk of future dementia.
    McCarter SJ; Stang C; Turcano P; Mielke MM; Ali F; Bower JH; Savica R
    Parkinsonism Relat Disord; 2020 Apr; 73():19-22. PubMed ID: 32203914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.